Drug development costs when financial risk is measured using the Fama–French three‐factor model
Year: 2009
Type: article
Source: Health Economics
DOI: 10.1002/hec.1538
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W1991153401
